含氟羟基磷灰石涂层体外细胞相容性研究

在羟基磷灰石（HA）中掺入氟可以降低其在体内的溶解性，对提高钛合金植入体表面生物活性改性层（涂层）的长效性有着重要的意义。本研究采用溶胶-凝胶法在钛合金基板上制备了含氟羟基磷灰石（Ca10（PO4）6（OH）2-xFx）（FHA）涂层。X光衍射（XRD）和X光电子能谱（XPS）分析结果显示：本实验中获得的涂层是一个纯磷灰石晶相，含氟涂层中x为1．2。在体外成骨细胞相容性的研究中，以HA涂层为对照，通过定时细胞的计数测定了细胞生长曲线，用流式细胞仪法测定了细胞周期，用MTT比色法分析了涂层浸提液的细胞毒性。实验结果表明：在HA涂层中引入氟后，FHA涂层浸提液对细胞毒性级别为0级，该涂层不但没有对细胞产生毒性，而且会促进成骨细胞的贴壁生长，有着更好的细胞生长速度和增殖活性。     

Mechanical Properties and Cytocompatibility Improvement of Vertebroplasty PMMA Bone Cements by Incorporating Mineralized Collagen

Polymethyl methacrylate (PMMA) bone cement is a commonly used bone adhesive and filling material in percutaneous vertebroplasty and percutaneous kyphoplasty surgeries. However, PMMA bone cements have been reported to cause some severe complications, such as secondary fracture of adjacent vertebral bodies, and loosening or even dislodgement of the set PMMA bone cement, due to the over-high elastic modulus and poor osteointegration ability of the PMMA. In this study, mineralized collagen (MC) with biomimetic microstructure and good osteogenic activity was added to commercially available PMMA bone cement products, in order to improve both the mechanical properties and the cytocompatibility. As the compressive strength of the modified bone cements remained well, the compressive elastic modulus could be significantly down-regulated by the MC, so as to reduce the pressure on the adjacent vertebral bodies. Meanwhile, the adhesion and proliferation of pre-osteoblasts on the modified bone cements were improved compared with cells on those unmodified, such result is beneficial for a good osteointegration formation between the bone cement and the host bone tissue in clinical applications. Moreover, the modification of the PMMA bone cements by adding MC did not significantly influence the injectability and processing times of the cement.     

蛛丝蛋白/聚己内酯/壳聚糖复合纳米纤维支架与内皮细胞的相容性

将RGD-重组蛛丝蛋白(pNSR32)、聚己内酯(PCL)和壳聚糖(CS)共混,应用静电纺丝技术制备复合纳米纤维支架(pNSR32/PCL/CS),进行细胞相容性的初步研究.选择体外细胞培养法,以内皮细胞为种子细胞,应用MTT比色法评价材料浸提液细胞毒性及材料对内皮细胞粘附、生长及增殖的影响,细胞免疫荧光法检测与支架复...     

Scaffold-Type Structure Dental Ceramics with Different Compositions Evaluated through Physicochemical Characteristics and Biosecurity Profiles

The design and development of ceramic structures based on 3D scaffolding as dental bone substitutes has become a topic of great interest in the regenerative dentistry research area. In this regard, the present study focuses on the development of two scaffold-type structures obtained from different commercial dental ceramics by employing the foam replication method. At the same time, the study underlines the physicochemical features and the biological profiles of the newly developed scaffolds, compared to two traditional Cerabone^® materials used for bone augmentation, by employing both the in vitro Alamar blue proliferation test at 24, 48 and 96 h poststimulation and the in ovo chick chorioallantoic membrane (CAM) assay. The data reveal that the newly developed scaffolds express comparable results with the traditional Cerabone^® augmentation masses. In terms of network porosity, the scaffolds show higher pore interconnectivity compared to Cerabone^® granules, whereas regarding the biosafety profile, all ceramic samples manifest good biocompatibility on primary human gingival fibroblasts (HGFs); however only the Cerabone^® samples induced proliferation of HGF cells following exposure to concentrations of 5 and 10 µg/mL. Additionally, none of the test samples induce irritative activity on the vascular developing plexus. Thus, based on the current results, the preliminary biosecurity profile of ceramic scaffolds supports the usefulness for further testing of high relevance for their possible clinical dental applications.     

Biocompatibility of two model elastin‐like recombinamer‐based hydrogels formed through physical or chemical cross‐linking for various applications in tissue engineering and regenerative medicine

Biocompatibility studies, especially innate immunity induction, in vitro and in vivo cytotoxicity, and fibrosis, are often lacking for many novel biomaterials including recombinant protein‐based ones, such as elastin‐like recombinamers (ELRs), and has not been extensively explored in the scientific literature, in contrast to traditional biomaterials. Herein, we present the results from a set of experiments designed to elucidate the preliminary biocompatibility of 2 types of ELRs that are able to form extracellular matrix‐like hydrogels through either physical or chemical cross‐linking both of which are intended for different applications in tissue engineering and regenerative medicine. Initially, we present in vitro cytocompatibility results obtained upon culturing human umbilical vein endothelial cells on ELR substrates, showing optimal proliferation up to 9 days. Regarding in vivo cytocompatibility, luciferase‐expressing hMSCs were viable for at least 4 weeks in terms of bioluminescence emission when embedded in ELR hydrogels and injected subcutaneously into immunosuppressed mice. Furthermore, both types of ELR‐based hydrogels were injected subcutaneously in immunocompetent mice and serum TNFα, IL‐1β, IL‐4, IL‐6, and IL‐10 concentrations were measured by enzyme‐linked immunosorbent assay, confirming the lack of inflammatory response, as also observed upon macroscopic and histological evaluation. All these findings suggest that both types of ELRs possess broad biocompatibility, thus making them very promising for tissue engineering and regenerative medicine‐related applications.     

Improved performance of collagen scaffolds crosslinked by Traut’s reagent and Sulfo-SMCC

Collagen scaffolds are frequently employed for applications in regenerative medicine. In previous studies, we affirmed that Traut’s reagent (2-Iminothiolane hydrochloride) and Sulfo-SMCC (4-(N-Maleimidomethyl) cyclohexane-1-carboxylic acid 3-sulpho-N-hydroxysuccinimide ester sodium salt) could covalently bind growth factors on collagen scaffolds. We also observed that crosslinking formed within the collagen scaffolds with excess dosage of Sulfo-SMCC, which improved the biological performance of collagen scaffolds together with growth factors. In order to evaluate changes in capacity caused by crosslinking, Traut’s reagent and adjusted different concentrations of Sulfo-SMCC (0.263, 1.315, 2.63 and 5.26 mM) were used to construct collagen scaffolds with differing extents of crosslinking in this study. The results demonstrated that resistance of collagen scaffolds to enzymatic digestion, cellularization and vascularization in vivo were enhanced by the crosslinking procedure. The cell culture studies indicated that the crosslinking procedure did not influence biocompatibility. Moreover, there were no statistical differences in the degradation rate, cellularization or vascularization among 1.315, 2.63 and 5.26 mM crosslinked groups. These results demonstrated that crosslinking collagen scaffolds with an appropriate amount of Traut’s reagent and Sulfo-SMCC was an effective and safe method to modify naturally derived collagen scaffolds with notable potential uses in tissue regeneration.     

Improvement of functionality after chitosan-modified zein biocomposites

A series of chitosan-modified zein composite films were fabricated from zein and chitosan by a process involving blending, solution casting and evaporation. Effects of chitosan content on the structure and physical properties of the composite films were investigated by Fourier transform infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy, tensile testing, water absorption measurement and water contact angle measurement. The results showed that the zein/chitosan composite films were fabricated successfully due to the formation of hydrogen bonds between zein and chitosan, and the thermal stability, water absorption, hydrophilicity, tensile strength, flexibility of the composite films increased with an increase in chitosan content from 0 to 50%. The cytotoxicity and cytocompatibility of the composite films were evaluated by 3-[45-dimethyl-2-thiazoly1]-25-diphenyl-2H-tetrazolium bromide (MTT) assay and in vitro cell culture, which showed that the films have non- or low-cytotoxicity, and chitosan promoted the growth, adhesion and proliferation of the cells. These results indicated that chitosan-modified zein composite films might have potentials applications as biomaterials.     

3D打印聚己内酯/纳米羟基磷灰石复合支架与骨髓间充质干细胞的体外生物相容性

文题释义： 3D打印技术：是通过计算机设计3D模型,按照某一坐标轴切成无限多个剖面,然后层层打印堆叠形成一个实体的立体模型,使用3D打印技术制备的骨组织工程支架能对支架的内部结构和外形进行自由可控的构建,在支架个性化、精确性、机械强度、孔隙调节、空间结构复杂性方面有独特优势。 纳米羟基磷灰石/聚己内酯复合材料：羟基磷灰石是人体和动物骨骼的主要无机成分,具有良好的骨诱导性,纳米羟基磷灰石由于良好的生物相容性和骨整合能力被广泛用作骨缺损的修复材料;聚己内酯是一种已被FDA批准的生物材料,具有良好的机械性能、生物相容性及降解性。两种材料复合物的多孔结构能够为细胞生长、组织再生及血管化提供有利条件。 背景：聚己内酯/纳米羟基磷灰石复合材料是在常用骨组织工程材料基础上结合3D打印技术制备的新型复合支架材料,目前对于该复合材料的体外生物相容性研究较少。 目的：通过体外实验探讨3D打印聚己内酯/纳米羟基磷灰石复合支架材料的细胞相容性。 方法：利用3D打印技术分别制备聚己内酯及聚己内酯/纳米羟基磷灰石复合支架,表征两组材料的微观结构、孔隙率及力学性能。将大鼠骨髓间充质干细胞分别接种于两组支架表面,CCK-8法检测细胞增殖率,扫描电镜和Live/Dead染色观察细胞在支架上的生长情况。 结果与结论：①两组支架均呈三维网状相互连通结构,纤维呈规律有序的排列、相互交错,纤维表面无空隙,纤维间距、直径较为均一;两组支架的孔隙率比较差异无显著性意义(P > 0.05);复合支架的弹性模量高于单纯聚己内酯支架(P < 0.05);②两组支架表面培养1 d的细胞增殖比较差异无显著性意义(P > 0.05),复合支架表面培养4,7 d的细胞增殖快于单纯聚己内酯支架(P < 0.05);③Live/Dead染色结果显示,两组材料均具有良好的细胞相容性,细胞活性较高,同时复合支架上的贴壁细胞更多一些;④扫描电镜显示,细胞在两种材料上生长形态良好,并紧密黏附于支架表面及微孔附近,同时可见分泌的细胞外基质呈丝状包绕于细胞周围;⑤结果表明,3D打印技术制备的聚己内酯/纳米羟基磷灰石复合支架孔隙较丰富,具备良好的力学性能,细胞相容性良好,可作为骨组织工程的支架材料。 ORCID: 0000-0002-7083-6458(胡超然) 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程     

壳聚糖/磷酸化壳聚糖纳米复合物的制备及细胞相容性研究

目的:由壳聚糖(chitosan,CS)和磷酸化壳聚糖(phosphorylated chitosan,PCS)通过静电自组装仿生合成一种新型骨修复材料并体外评价其细胞相容性。方法:对CS进行磷酸根接枝,合成PCS,然后将PCS溶液逐滴滴加到CS的醋酸溶液中,得到壳聚糖/磷酸化壳聚糖复合物(CS/PCS)。将CS/PCS水胶体置于饱和的Ca(OH)_2溶液中矿化供细胞培养用。第3～5代成骨细胞与矿化后的CS/PCS复合物共同培养,以羟基磷灰石组为对照组。倒置显微镜下观察细胞的黏附、生长情况。MTT法检测细胞的增殖;碱性磷酸酶(alkaline phosphatase,ALP)检测细胞的分化。结果:CS/PCS复合物呈多孔网状结构,矿化后的CS/PCS可以促进成骨细胞的增殖和分化。结论:仿生合成的CS/PCS复合水胶体矿化后显示了良好的细胞相容性,可以促进成骨细胞的增殖和分化,可作为一种新型的骨修复材料。